Dal İsmail, Bektaş Özgür, Kader Sibel, Bodur Gözde
Department of Thoracic Surgery, Kastamonu University, Kastamonu, Turkey.
Department of Physical Therapy and Rehabilitation, Kastamonu University, Kastamonu, Turkey.
J Pain Res. 2024 Dec 12;17:4239-4247. doi: 10.2147/JPR.S500974. eCollection 2024.
The aim of this study is to investigate the effect of kinesiotaping on pain scores in patients with rib fractures following isolated thoracic trauma.
In this randomized prospective study, patients with isolated thoracic trauma and rib fractures were randomized into kinesiotaping and control groups between January 24, 2024, and October 1, 2024. Patients in the control group received standard analgesic treatment. In the kinesiotaping group, kinesiotaping bands were applied in addition to the standard treatment. Pain scores using the visual analog scale (VAS) were recorded at admission, the 24th hour, the 4th day, and the 7th day, and the results were statistically compared.
A total of 118 patients were evaluated. Eighty-four patients did not meet the inclusion criteria. The 34 patients included in the study were randomized into kinesiotaping and control groups. The two groups were demographically homogeneous. On the 4th day, the mean VAS score was significantly lower in the kinesiotaping group (2.7 ± 1.2) compared to the control group (4.1 ± 1.9) (p = 0.037). No statistically significant difference in VAS scores was observed on the other days.
In patients with rib fractures, pain scores decreased more rapidly in those treated with analgesics plus kinesiotaping compared to those treated with analgesics alone.
ClinicalTrials.gov, NCT06222320. Registered on January 15, 2024.
本研究旨在探讨肌内效贴布对单纯胸部创伤后肋骨骨折患者疼痛评分的影响。
在这项随机前瞻性研究中,2024年1月24日至2024年10月1日期间,将单纯胸部创伤和肋骨骨折患者随机分为肌内效贴布组和对照组。对照组患者接受标准镇痛治疗。肌内效贴布组在标准治疗基础上加用肌内效贴布。分别在入院时、第24小时、第4天和第7天记录视觉模拟量表(VAS)疼痛评分,并对结果进行统计学比较。
共评估了118例患者。84例患者不符合纳入标准。纳入研究的34例患者被随机分为肌内效贴布组和对照组。两组在人口统计学上具有同质性。在第4天,肌内效贴布组的平均VAS评分为(2.7±1.2),显著低于对照组(4.1±1.9)(p = 0.037)。在其他时间点,VAS评分未观察到统计学显著差异。
在肋骨骨折患者中,与单纯使用镇痛药治疗的患者相比,使用镇痛药加肌内效贴布治疗的患者疼痛评分下降更快。
ClinicalTrials.gov,NCT06222320。于2024年1月15日注册。